日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Buffy Coat Enrichment Improves the Success Rate of Conventional Cytogenetics in Hypocellular Specimens: A Prospective Quality Improvement Study

白细胞层富集可提高低细胞标本常规细胞遗传学检测的成功率:一项前瞻性质量改进研究

Bai, Ziyi; Lan, Tianxia; Hong, Weiqi; Que, Haiying; Zhu, Min; Xiao, Xin; Wan, Dandan; Ai, Jiayuan; Huang, Shaoxiong; Wang, Jiayu; Hong, Qiaonan; Liu, Yanyan; Xiao, Chengxin; Zhao, Chengjian; Wang, Xin; Zhang, Xiaolong; Yang, Ting; Xu, Heng; Dai, Lunzhi; Powell, Charles A; Richeldi, Luca; Luo, Fengming; Dong, Haohao; Yuan, Yong; Pu, Qiang; Wei, Xiawei; Toruner, Gokce A; Imtiaz, Nawal; McCoy, Andrew M; Robinson, Melissa; Cardona, Griselda J; Delgado, Sarita S; Yang, Su; Wei, Qing; Medeiros, L Jeffrey; Tang, Guilin

Deficiency of lysosomal TMEM175 in myeloid macrophages exerts anti-tumor immunity via inflammasome and cross-presentation pathway.

髓系巨噬细胞中溶酶体 TMEM175 的缺乏通过炎症小体和交叉呈递途径发挥抗肿瘤免疫作用。

Zhang Ziqi, Li Xue, Lu Tianqi, Yang Jingyun, Han Xuejiao, Bi Zhenfei, Luo Jingwen, Alu Aqu, Hong Weiqi, Chen Siyuan, Chen Lei, Cheng Yuan, He Xuemei, Zhu Chenjing, Wang Manni, Li Qingfang, Wang Yang, Li Lu, Lei Hong, Lan Jie, Geng Jia, Wei Yuquan, Wei Xiawei

Combination of adenovirus vector and subunit protein elicits a robust immune response against the SARS-CoV-2 Omicron variant

腺病毒载体与亚单位蛋白的组合可诱导针对SARS-CoV-2 Omicron变异株的强效免疫反应。

Ye, Chunjun; Huang, Xiya; Hong, Weiqi; Shi, Jie; Ao, Danyi; Zhang, Yu; Lu, Yishan; Zhou, Yingqiong; Song, Zhiruo; Zhang, Yu; Liu, Yanyan; Cheng, Ping; Lu, Guangwen; Li, Jiong; Song, Xiangrong; Wei, Xiawei

Immunosenescence: signaling pathways, diseases and therapeutic targets

免疫衰老:信号通路、疾病和治疗靶点

Fu, Yichu; Wang, Binhan; Alu, Aqu; Hong, Weiqi; Lei, Hong; He, Xuemei; Shi, Huashan; Cheng, Ping; Yang, Xiangliang

A recombinant protein vaccine induces protective immunity against SARS-CoV-2 JN.1 and XBB-lineage subvariants.

重组蛋白疫苗可诱导针对 SARS-CoV-2 JN.1 和 XBB 谱系亚变种的保护性免疫

Yang Jingyun, Hong Weiqi, Shi Huashan, Wang Zhenling, He Cai, Lei Hong, Yan Hong, Alu Aqu, Ao Danyi, Chen Zimin, Zhou Yanan, Yang Hao, Yang Yun, Yu Wenhai, Tang Cong, Wang Junbin, Li Bai, Huang Qing, Hu Hongbo, Cheng Wei, Dong Haohao, Lei Jian, Chen Lu, Zhou Xikun, Yang Li, Wang Wei, Shen Guobo, Yang Jinliang, Zhao Zhiwei, Song Xiangrong, Sun Qiangming, Wang Youchun, Lu Shuaiyao, Li Jiong, Lu Guangwen, Li Weimin, Wei Yuquan, Wei Xiawei

Enhancing antitumor immunity through the combination of cholesterolized TLR7 agonist liposomes and radiotherapy: a role for IL-1β and the inflammasome pathway.

通过胆固醇化 TLR7 激动剂脂质体和放射疗法的结合增强抗肿瘤免疫力:IL-1β 和炎症小体通路的作用

Han Xuejiao, Cheng Yuan, Wan Dandan, Alu Aqu, Zhang Ziqi, Bi Zhenfei, Wang Manni, Tang Yan, Hong Weiqi, Chen Siyuan, Chen Li, Wei Yuquan

Intranasal Inoculation of Cationic Crosslinked Carbon Dots-Adjuvanted Respiratory Syncytial Virus F Subunit Vaccine Elicits Mucosal and Systemic Humoral and Cellular Immunity.

鼻内接种阳离子交联碳点佐剂呼吸道合胞病毒F亚单位疫苗可诱导粘膜和全身体液及细胞免疫

Lei Hong, Alu Aqu, Yang Jingyun, He Cai, Shi Jie, Hong Weiqi, Peng Dandan, Zhang Yu, Liu Jian, Qin Furong, Huang Xiya, Ye Chunjun, Pei Lijiao, He Xuemei, Yan Hong, Lu Guangwen, Song Xiangrong, Wei Xiawei, Wei Yuquan

Correction: A promising mRNA vaccine derived from the JN.1 spike protein confers protective immunity against multiple emerged Omicron variants

更正:一种源自 JN.1 刺突蛋白的有前景的 mRNA 疫苗可提供针对多种新出现的 Omicron 变种的保护性免疫力。

Ao, Danyi; Peng, Dandan; He, Cai; Ye, Chunjun; Hong, Weiqi; Huang, Xiya; Lu, Yishan; Shi, Jie; Zhang, Yu; Liu, Jian; Wei, Xiawei; Wei, Yuquan

A promising mRNA vaccine derived from the JN.1 spike protein confers protective immunity against multiple emerged Omicron variants.

一种源自 JN.1 刺突蛋白的有前景的 mRNA 疫苗可对多种新出现的 Omicron 变种提供保护性免疫

Ao Danyi, Peng Dandan, He Cai, Ye Chunjun, Hong Weiqi, Huang Xiya, Lu Yishan, Shi Jie, Zhang Yu, Liu Jian, Wei Xiawei, Wei Yuquan

Mucosal immunity and vaccination strategies: current insights and future perspectives

黏膜免疫和疫苗接种策略:当前认识和未来展望

Zhang, Zhihao; Hong, Weiqi; Zhang, Yu; Li, Xin; Que, Haiying; Wei, Xiawei